You have 9 free searches left this month | to do more
Showing 1 - 25 of
5,447 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
D
Active, not recruiting
  • Burkitt Lymphoma
  • +2 more
  • mNavigator
  • Mwanza, Lake Zone, Tanzania
    Bugando Medical Centre
2022-03-07
Mar 7, 2022
N
Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-31
Mar 31, 2022
N
Recruiting
  • B-cell Lymphoma
  • +8 more
  • Polatuzumab vedotin
  • Valhalla, New York
    New York Medical Center
2021-10-29
Oct 29, 2021
B
Recruiting
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
  • +11 more
  • Atlanta, Georgia
  • +1 more
2021-02-22
Feb 22, 2021
F
Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
2022-03-09
Mar 9, 2022
N
Recruiting
  • Non-Hodgkin Lymphoma
  • +5 more
  • Valhalla, New York
    New York Medical College
2021-09-01
Sep 1, 2021
P
Recruiting
  • Mature B-Cell Leukemia Burkitt Type
  • +2 more
  • Badalona, Barcelona, Spain
  • +28 more
2021-09-17
Sep 17, 2021
D
Recruiting
  • Grade 3a Follicular Lymphoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Atlanta, Georgia
  • +1 more
2021-05-13
May 13, 2021
W
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
  • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
2021-10-13
Oct 13, 2021
C
Not yet recruiting
  • High-grade B-cell Lymphoma
  • +8 more
  • Sepantronium Bromide
  • Busan, Korea, Republic of
  • +5 more
2022-02-27
Feb 27, 2022
C
Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
2022-03-28
Mar 28, 2022
F
Recruiting
  • Burkitt Lymphoma
  • OBSERVATIONAL
  • Ouagadougou, Burkina Faso
  • +6 more
2021-10-26
Oct 26, 2021
C
Recruiting
  • Refractory Non-Hodgkin Lymphoma
  • +8 more
  • San Francisco, California
    University of California, San Francisco
2021-08-20
Aug 20, 2021
C
Recruiting
  • Acute Leukemia
  • +7 more
  • CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
2022-03-21
Mar 21, 2022
C
Completed
  • Adult Solid Tumor
  • +2 more
  • Sutton, London, United Kingdom
  • +5 more
2021-08-16
Aug 16, 2021
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Fludarabine (FLU)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2021-08-13
Aug 13, 2021
H
Recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
2022-01-26
Jan 26, 2022
N
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
2021-10-29
Oct 29, 2021
B
Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021
U
Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
2021-05-10
May 10, 2021
M
Not yet recruiting
  • B-cell Lymphoma
  • Burkitt Lymphoma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
2022-03-06
Mar 6, 2022